Alpha Cognition (NASDAQ:ACOG) Given “Buy” Rating at HC Wainwright

Alpha Cognition (NASDAQ:ACOG)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research note issued on Friday,Benzinga reports. They currently have a $18.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 209.28% from the stock’s current price.

Several other analysts also recently commented on ACOG. Craig Hallum initiated coverage on shares of Alpha Cognition in a research report on Friday, April 17th. They issued a “buy” rating and a $14.00 target price for the company. Wall Street Zen downgraded shares of Alpha Cognition from a “hold” rating to a “sell” rating in a research report on Saturday, May 2nd. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $16.00.

Alpha Cognition Stock Performance

Alpha Cognition stock opened at $5.82 on Friday. The firm has a market cap of $126.72 million, a PE ratio of -4.31 and a beta of 2.38. The firm’s 50 day moving average price is $6.07 and its two-hundred day moving average price is $5.90. Alpha Cognition has a twelve month low of $4.50 and a twelve month high of $11.54.

Alpha Cognition (NASDAQ:ACOG) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.37) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.04. The firm had revenue of $3.53 million for the quarter, compared to analyst estimates of $3.42 million. Alpha Cognition had a negative net margin of 232.23% and a negative return on equity of 58.35%. Equities analysts anticipate that Alpha Cognition will post -1.34 EPS for the current fiscal year.

Institutional Trading of Alpha Cognition

Large investors have recently modified their holdings of the company. Green Alpha Advisors LLC bought a new stake in shares of Alpha Cognition during the 4th quarter worth $72,000. Geode Capital Management LLC bought a new stake in shares of Alpha Cognition during the 2nd quarter worth $112,000. Berkshire Asset Management LLC PA boosted its holdings in shares of Alpha Cognition by 50.7% during the 3rd quarter. Berkshire Asset Management LLC PA now owns 17,824 shares of the company’s stock worth $116,000 after buying an additional 6,000 shares during the period. Massar Capital Management LP bought a new stake in shares of Alpha Cognition during the 2nd quarter worth $116,000. Finally, Two Sigma Investments LP bought a new stake in shares of Alpha Cognition during the 3rd quarter worth $148,000.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.